ALPS Medical Breakthroughs ETF | SBIORegistrer deg for å få tilgang til rangeringer |
Avkastningshistorikk | 30.04.2024 |
Vekst av 1 000 (NOK) | Mer detaljert graf |
Fond | 18,1 | -15,1 | -19,7 | 12,0 | 8,5 | |
+/- Kat | -6,3 | -25,2 | -14,4 | 5,6 | 0,0 | |
+/- Idx | 4,8 | -37,2 | -10,9 | -13,9 | -5,5 | |
Kategori: Health | ||||||
Referanseindekser: MSCI ACWI NR USD |
Statistikk | ||
sluttkurs 17.05.2024 | USD 34,09 | |
Endring 1 dag | -1,47% | |
Morningstar Kategori™ | Health | |
Volum | 3860 | |
Exchange | NYSE ARCA | |
ISIN | US00162Q5936 | |
Fondets størrelse(m) - | - | |
Andelskl. kapital(m) 17.05.2024 | USD 109,10 | |
Løpende kostnader - | -% |
Investeringsprofil: ALPS Medical Breakthroughs ETF | SBIO |
The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network® Medical Breakthroughs Index. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials. |
Avkastning | |||||||||||||
|
Forvaltning | ||
Navn på forvalter Forvaltet siden | ||
Ryan Mischker 31.03.2015 | ||
Andrew Hicks 31.03.2016 | ||
Klikk for å se flere | ||
Startdato 30.12.2014 |
Annonse |
Referanseindekser | |
Fondets referanseindeks | Morningstar referanseindeks |
S-Network Medical Breakthroughs TR USD | MSCI ACWI NR USD |
Målgruppe | ||||||||||||||||||||
|
Porteføljeprofil ALPS Medical Breakthroughs ETF | SBIO | 17.05.2024 |
|
|
Topp 5 beholdninger | Sektor | % |
Vaxcyte Inc Ordinary Shares | Helsetjenester | 5,17 |
Cerevel Therapeutics Holdings In... | Helsetjenester | 4,90 |
Viking Therapeutics Inc | Helsetjenester | 4,51 |
Revolution Medicines Inc Ordinar... | Helsetjenester | 4,16 |
Alpine Immune Sciences Inc | Helsetjenester | 2,73 |
Økning Nedgang Ny siden forrige portefølje | ||
ALPS Medical Breakthroughs ETF | SBIO |